Whether you’ve been living with immune thrombocytopenia (ITP) for months or years, there’s no denying that the condition can throw some curveballs your way. Part of that is because ITP can cause ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

Most experts would treat you for one to two weeks, then taper the medicine off over a few weeks. The side effects of this dose of steroids are modest if it does not need to be frequently repeated.

Researchers have created nanoparticles that mimic the effects of blood platelets to stop heavy bleeding. Biomedical engineer and research lead, Anirban Sen Gupta, said: “This is the next step in ...

Biomedical researchers at Case Western Reserve University report that their latest innovation in developing synthetic platelets could help save lives by rapidly stabilizing clots to reduce blood loss ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

The use of cryopreserved platelets is associated with higher perioperative blood loss, higher transfusion use, and longer ICU ...

Thrombocytopenia is an atypically low platelet count. Acquired thrombocytopenia is caused by conditions that develop throughout your life instead of genes inherited from birth. Acquired ...

More than two million platelet units are needed in the United States every year. However, natural platelets aren’t always available or portable, have a high risk of contamination, and have a limited ...